Research Funded To Date
The Ben and Catherine Ivy Foundation is dedicated to finding a cure for brain cancer. We strive in improve the quality of life and increase the life expectancy of those diagnosed with brain cancer by funding promising research that creates more diagnostics and treatments for patients.
Since 2008, we have funded 33 separate institutions with over 107 different research grants totaling over $150 million. These grants have involved research in phase 0 clinical trials, biomarkers, genomics, imaging, immunotherapy, stem cell, vaccines, and the development of possible new drugs.
PI: Brandy Wells
Director, Public Affairs and Education
Translational Genomics Research Institute (TGen)
PI: Yolanda P. Konopken RD, CDE
Director, Family Wellness Program
Society of St. Vincent de Paul
PIs: Timothy Cloughesy, M.D.
Director and Professor
University of California Los Angeles (UCLA)
James R. Heath, Ph.D.
Elizabeth W. Gilloon Professor
California Institute of Technology
Paul S. Mischel, M.D.
Member, Head and Professor
Laboratory of Molecular Pathology
Ludwig Institute for Cancer Research
University of California at San Diego
PI: Ralph B. Puchalski, Ph.D.
Ivy Center for Advanced Brain Tumor Treatment
Swedish Neuroscience Institute
PI: Kristin R. Swanson, Ph.D.
Co-Director, Precision NeuroTherapeutics Innovation Program
Director, Mathematical NeuroOncology Lab
Professor and Vice Chair of Research, Neurosurgery
PI: Amy B. Heimberger, M.D.
MD Anderson Cancer Center
PI: Sanjiv Sam Gambhir M.D., Ph.D.
Chair, Department of Radiology
Director, Molecular Imaging Program at Stanford
Director, Canary Center at Stanford for Cancer Early Detection
Stanford University School of Medicine
PI: David A. Reardon, M.D.
Professor of Medicine, Harvard Medical School
Clinical Director, Center for Neuro-Oncology
Dana-Farber Cancer Institute